Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
68,808
+1,754
+3% +$45.9K 0.12% 119
2026
Q1
$1.88M Buy
67,054
+7,524
+13% +$200K 0.15% 109
2025
Q4
$1.48M Buy
59,530
+3,072
+5% +$77.5K 0.12% 123
2025
Q3
$1.44M Buy
56,458
+5,862
+12% +$145K 0.12% 122
2025
Q2
$1.23M Buy
50,596
+303
+0.6% +$7.07K 0.11% 139
2025
Q1
$1.27M Buy
50,293
+9,204
+22% +$241K 0.13% 128
2024
Q4
$1.09M Sell
41,089
-6,893
-14% -$187K 0.11% 140
2024
Q3
$1.39M Buy
47,982
+2,360
+5% +$68.8K 0.14% 121
2024
Q2
$1.28M Sell
45,622
-1,945
-4% -$53.5K 0.14% 122
2024
Q1
$1.32M Sell
47,567
-6,774
-12% -$188K 0.14% 122
2023
Q4
$1.56M Sell
54,341
-5,805
-10% -$175K 0.18% 105
2023
Q3
$2M Sell
60,146
-6,643
-10% -$235K 0.25% 75
2023
Q2
$2.45M Buy
66,789
+1,103
+2% +$42.9K 0.3% 60
2023
Q1
$2.68M Sell
65,686
-3,840
-6% -$166K 0.34% 48
2022
Q4
$3.56M Buy
69,526
+4,050
+6% +$194K 0.49% 35
2022
Q3
$2.87M Sell
65,476
-4,997
-7% -$243K 0.44% 39
2022
Q2
$3.69M Sell
70,473
-590
-0.8% -$30.1K 0.53% 33
2022
Q1
$3.68M Buy
71,063
+737
+1% +$38.2K 0.47% 36
2021
Q4
$4.15M Sell
70,326
-216
-0.3% -$10.7K 0.5% 31
2021
Q3
$3.03M Sell
70,542
-473
-0.7% -$21K 0.4% 39
2021
Q2
$2.78M Buy
71,015
+1,361
+2% +$52.9K 0.38% 48
2021
Q1
$2.52M Sell
69,654
-2,515
-3% -$89.3K 0.36% 52
2020
Q4
$2.66M Buy
72,169
+387
+0.5% +$14.2K 0.4% 44
2020
Q3
$2.5M Buy
71,782
+4,654
+7% +$163K 0.44% 44
2020
Q2
$2.08M Buy
67,128
+6,306
+10% +$214K 0.41% 53
2020
Q1
$1.88M Sell
60,822
-4,447
-7% -$152K 0.53% 42
2019
Q4
$2.43M Buy
65,269
+492
+0.8% +$17.5K 0.55% 38
2019
Q3
$2.21M Sell
64,777
-6,359
-9% -$231K 0.55% 36
2019
Q2
$2.92M Buy
71,136
+709
+1% +$28.2K 0.71% 27
2019
Q1
$2.84M Sell
70,427
-3,552
-5% -$142K 0.72% 24
2018
Q4
$3.06M Buy
73,979
+5,373
+8% +$223K 0.89% 17
2018
Q3
$2.87M Buy
68,606
+2,349
+4% +$90.4K 0.73% 25
2018
Q2
$2.28M Sell
66,257
-1,639
-2% -$56K 0.63% 29
2018
Q1
$2.29M Sell
67,896
-2,889
-4% -$99.3K 0.66% 27
2017
Q4
$2.43M Buy
70,785
+1,603
+2% +$54.7K 0.72% 27
2017
Q3
$2.34M Buy
69,182
+390
+0.6% +$12.5K 0.77% 26
2017
Q2
$2.19M Buy
68,792
+1,682
+3% +$53K 0.75% 24
2017
Q1
$2.18M Buy
67,110
+2,124
+3% +$67K 0.77% 26
2016
Q4
$2M Sell
64,986
-228
-0.3% -$6.96K 0.76% 25
2016
Q3
$2.1M Sell
65,214
-4,174
-6% -$140K 0.83% 21
2016
Q2
$2.32M Buy
69,388
+63
+0.1% +$2.01K 0.94% 17
2016
Q1
$1.95M Buy
69,325
+20,389
+42% +$582K 0.7% 40
2015
Q4
$1.5M Sell
48,936
-2,985
-6% -$93.9K 0.56% 55
2015
Q3
$1.55M Sell
51,921
-7,436
-13% -$238K 0.59% 56
2015
Q2
$1.89M Sell
59,357
-9,513
-14% -$310K 0.66% 42
2015
Q1
$2.27M Buy
68,870
+12,377
+22% +$393K 0.8% 31
2014
Q4
$1.67M Buy
56,493
+1,826
+3% +$52.4K 0.62% 44
2014
Q3
$1.53M Buy
54,667
+8,719
+19% +$245K 0.59% 46
2014
Q2
$1.29M Buy
45,948
+9,821
+27% +$280K 0.48% 60
2014
Q1
$1.1M Buy
36,127
+6,543
+22% +$195K 0.45% 63
2013
Q4
$860K Sell
29,584
-7,517
-20% -$219K 0.37% 75
2013
Q3
$1.01M Sell
37,101
-7,747
-17% -$211K 0.49% 57
2013
Q2
$1.19M Buy
+44,848
New +$1.24M 0.53% 40

Other funds holding PFE

Intrust Bank's PFE Position: Q2 2026 in Review

Intrust Bank increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $45.9K and bringing the position to 68,808 shares worth $1.66M. The position accounts for 0.12% of the portfolio, ranked #119.

Intrust Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.15M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Intrust Bank held 68,808 shares of Pfizer worth $1.66M as of Q2 2026.
  • Intrust Bank bought 1,754 Pfizer shares in Q2 2026, an estimated $45.9K.
  • Pfizer made up 0.12% of Intrust Bank's portfolio in Q2 2026, its #119 holding.
  • Intrust Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Intrust Bank's Pfizer position peaked at $4.15M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.